KRAS and neoplasm: Assuming, for example, a sensitivity limit of 5% to detect K-RAS mutations by Pyrosequencing, the starting percentage of morphologically enriched tumor cells should vary between 46.3% and 5.1% for tumors highly or barely heterogeneous for the tested mutation, respectively.